Request for Covid-19 Impact Assessment of this Report
The global Chemotherapy-Induced Nausea and Vomiting Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Existing Drugs
Akynzeo (Netupitant-Palonosetron FDC)
Aloxi (Palonosetron)
Emend (Aprepitant)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
Pipeline Drugs
SUSTOL (Granisetron Injection extended release)
Rolapitant
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Merck & Co., Inc.
GlaxoSmithKline plc
Tesaro, Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy's Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Serotonin Receptor Antagonists
NK1 Receptor Antagonists
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Existing Drugs
1.2.1.2 Akynzeo (Netupitant-Palonosetron FDC)
1.2.1.3 Aloxi (Palonosetron)
1.2.1.4 Emend (Aprepitant)
1.2.1.5 Kytril Generic (Granisetron)
1.2.1.6 Zofran Generic (Ondansetron)
1.2.1.7 Pipeline Drugs
1.2.1.8 SUSTOL (Granisetron Injection extended release)
1.2.1.9 Rolapitant
1.2.2 by Application
1.2.2.1 Serotonin Receptor Antagonists
1.2.2.2 NK1 Receptor Antagonists
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Existing Drugs Market, 2013-2018
4.1.2 Akynzeo (Netupitant-Palonosetron FDC) Market, 2013-2018
4.1.3 Aloxi (Palonosetron) Market, 2013-2018
4.1.4 Emend (Aprepitant) Market, 2013-2018
4.1.5 Kytril Generic (Granisetron) Market, 2013-2018
4.1.6 Zofran Generic (Ondansetron) Market, 2013-2018
4.1.7 Pipeline Drugs Market, 2013-2018
4.1.8 SUSTOL (Granisetron Injection extended release) Market, 2013-2018
4.1.9 Rolapitant Market, 2013-2018
4.2 Market Forecast
4.2.1 Existing Drugs Market Forecast, 2019-2024
4.2.2 Akynzeo (Netupitant-Palonosetron FDC) Market Forecast, 2019-2024
4.2.3 Aloxi (Palonosetron) Market Forecast, 2019-2024
4.2.4 Emend (Aprepitant) Market Forecast, 2019-2024
4.2.5 Kytril Generic (Granisetron) Market Forecast, 2019-2024
4.2.6 Zofran Generic (Ondansetron) Market Forecast, 2019-2024
4.2.7 Pipeline Drugs Market Forecast, 2019-2024
4.2.8 SUSTOL (Granisetron Injection extended release) Market Forecast, 2019-2024
4.2.9 Rolapitant Market Forecast, 2019-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Serotonin Receptor Antagonists Market, 2013-2018
5.1.2 NK1 Receptor Antagonists Market, 2013-2018
5.2 Market Forecast
5.2.1 Serotonin Receptor Antagonists Market Forecast, 2019-2024
5.2.2 NK1 Receptor Antagonists Market Forecast, 2019-2024
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Merck & Co., Inc.
8.2 GlaxoSmithKline plc
8.3 Tesaro, Inc.
8.4 Helsinn Group
8.5 F. Hoffmann-La Roche Ltd.
8.6 Heron Therapeutics, Inc.
8.7 Dr. Reddy's Laboratories Ltd.
8.8 Acacia Pharma
8.9 Sun Pharmaceutical Industry Ltd.
8.10 Otsuka Holdings Co., Ltd.
9 Conclusion
Table Products Segment of Chemotherapy-Induced Nausea and Vomiting Drugs
Table Existing Drugs Overview
Table Akynzeo (Netupitant-Palonosetron FDC) Overview
Table Aloxi (Palonosetron) Overview
Table Emend (Aprepitant) Overview
Table Kytril Generic (Granisetron) Overview
Table Zofran Generic (Ondansetron) Overview
Table Pipeline Drugs Overview
Table SUSTOL (Granisetron Injection extended release) Overview
Table Rolapitant Overview
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Type, 2011-2022 (USD Million)
Table Application Segment of Chemotherapy-Induced Nausea and Vomiting Drugs
Table Serotonin Receptor Antagonists Overview
Table NK1 Receptor Antagonists Overview
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Application, 2011-2022 (USD Million)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Region, 2011-2022 (USD Million)
Table Cost of Chemotherapy-Induced Nausea and Vomiting Drugs
Table Market Dynamics
Table Policy of Chemotherapy-Induced Nausea and Vomiting Drugs
Table GDP of Major Countries
Table Existing Drugs CAGR by Revenue and Volume, 2012-2018
Table Akynzeo (Netupitant-Palonosetron FDC) CAGR by Revenue and Volume, 2012-2018
Table Aloxi (Palonosetron) CAGR by Revenue and Volume, 2012-2018
Table Emend (Aprepitant) CAGR by Revenue and Volume, 2012-2018
Table Kytril Generic (Granisetron) CAGR by Revenue and Volume, 2012-2018
Table Zofran Generic (Ondansetron) CAGR by Revenue and Volume, 2012-2018
Table Pipeline Drugs CAGR by Revenue and Volume, 2012-2018
Table SUSTOL (Granisetron Injection extended release) CAGR by Revenue and Volume, 2012-2018
Table Rolapitant CAGR by Revenue and Volume, 2012-2018
Table Existing Drugs CAGR by Revenue and Volume, 2012-2024
Table Akynzeo (Netupitant-Palonosetron FDC) CAGR by Revenue and Volume, 2012-2024
Table Aloxi (Palonosetron) CAGR by Revenue and Volume, 2012-2024
Table Emend (Aprepitant) CAGR by Revenue and Volume, 2012-2024
Table Kytril Generic (Granisetron) CAGR by Revenue and Volume, 2012-2024
Table Zofran Generic (Ondansetron) CAGR by Revenue and Volume, 2012-2024
Table Pipeline Drugs CAGR by Revenue and Volume, 2012-2024
Table SUSTOL (Granisetron Injection extended release) CAGR by Revenue and Volume, 2012-2024
Table Rolapitant CAGR by Revenue and Volume, 2012-2024
Table Serotonin Receptor Antagonists CAGR by Revenue and Volume, 2012-2018
Table NK1 Receptor Antagonists CAGR by Revenue and Volume, 2012-2018
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Vendors, 2012-2018 (USD Million)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Vendors, 2012-2018 (in Volume)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Vendors, 2012-2018 (USD Million)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Merck & Co., Inc. Profile List
Table Microecological Modulator Operating Data of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline plc Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Tesaro, Inc. Profile List
Table Microecological Modulator Operating Data of Tesaro, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Helsinn Group Profile List
Table Microecological Modulator Operating Data of Helsinn Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Profile List
Table Microecological Modulator Operating Data of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Heron Therapeutics, Inc. Profile List
Table Microecological Modulator Operating Data of Heron Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Reddy's Laboratories Ltd. Profile List
Table Microecological Modulator Operating Data of Dr. Reddy's Laboratories Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Acacia Pharma Profile List
Table Microecological Modulator Operating Data of Acacia Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sun Pharmaceutical Industry Ltd. Profile List
Table Microecological Modulator Operating Data of Sun Pharmaceutical Industry Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Otsuka Holdings Co., Ltd. Profile List
Table Microecological Modulator Operating Data of Otsuka Holdings Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...